Navigation Links
Trigger Finger System

ProductsTrigger Finger System
Company Smith & Nephew, Inc. - Endoscopy
Item Trigger Finger System
Features 
Description In conjunction with Yasushi Nakao, M.D., Smith & Nephew has developed an endoscopic approach to flexor tendon release for fingers and thumbs due to stenosing tenosynovitis. Our minimally invasive approach is designed to decrease patient discomfort while incorporating the maximum safety element of releasing the A1 pulley under direct endoscopic vision. The system and technique combine to minimize patient risk commonly associated with conventional open or blind percutaneous techniques.
Info Smith & Nephew, Inc. - Endoscopy
Customer Service: (978) 749-1000
Web site: http://endo.smith-nephew.com

Related medicine products :

1. Two Trigger Full Function Handpiece
2. Single Trigger Handpiece
3. Two Trigger Standard Handpiece
4. MicroFinger Irrigating Nucleus Chopper
5. Cervical Retractor With Double Finger Hold
6. NeuFlex™ MCP/PIP Finger Joint Implant Systems
7. Swanson Finger Joint Implants
8. Swanson Finger Pins
9. Finger Clip Electrodes
10. Finger prosthesis, small, proximal
11. Finger prosthesis, long, proximal
WEBeDoctor® Physician-office® is an internet productivity tool for physicians, (Solo practice, group practice and managed care), to complete their normal duties in a practice. It is a front
...the core applications for health information manag...ical record. The suite includes applications for c...letion & release of information., Implemented...HARMS 2000 modules leverage the most sophisticated...
...ts, Care Management, I/O, Flow Sheets, Medication ...nd Therapies are accessible. Vitals and other peri...of care on a wireless handheld terminal so the com...mmary gives longitudinal view of patients health s...
...s a subscription-based service, which enables you ...tware without purchasing or maintaining the electr...r server. All you need is a broadband Internet con...o connect to your patient medical record database;...
Medicine Products:
(Date:7/25/2008)...fense and Federal Agencies in, the execution of O...is a, four-day, multi-agency collaborative train...ocal agencies with large and complex incident resp...ad-hoc, secure mobile communications infrastruct..., Va., July 25 /PRNewswire/ -- Dataline LLC is ple...
(Date:7/25/2008)... J. Reilly, Joins Aethon Team, PITTSBURGH, July 2...com ), the leading developer of mobile robotics fo... that Robert J. Reilly has,joined the company as S... Reilly, who was most recently Vice President -- G...y Pharmacy Division, brings more than 30,years of ...
(Date:7/25/2008)...e presented at Fenway Park ...swire/ -- CVS/pharmacy announced today,that this y...n just 21 days,through its annual in-store fundrai...h year of the annual fundraising effort which, to ...earch. This year,s fundraiser took,place in CVS/ph...
(Date:7/25/2008)...rop pounds, study finds , , FRIDAY, July...day morning weigh-ins knows this unalterable truth...searchers have some science to back up dieters, co...people do eat more on the weekend, even when they,...s can wreak havoc on weight control, either causin...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
...ecent research it was found that teenagers who wer...s to other hard drugs// later in their life. Teen...ife due to the positive emotion that they derive b...dered to be the gateway drug which further leads a...
...al clefting leaves some with psychological problem...t of oral clefting on quality of life can be used ...st effectiveness of prevention and treatment. Or...birth defects. The impact of oral clefting can be ...
...roven to significantly improve the vision of elder...The drug, Lucentis, is to treat age-related macula...s behind the retina leak, worsening vision and oft... the 1.4 million Americans, who have lost their vi...
... the University of Melbourne are claiming that the...such as diabetes and multiple sclerosis in humans/...elbourne have enlisted 100 domestic dogs in their ...etic make-up, causes diseases. The researchers aim...
Other Medicine News:Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2Health News:DNA Of Dog Could Hold The Key To Combat Human Diseases. 2
(Date:7/22/2008)...rom a multi-center 293-patient European, trial -,...ge Symbol: CYT, MONTREAL, July 22 /PRNewswire-Fir...l leader in cryotherapy products to treat cardiac,...ly presented from three,European study centers usi...re published earlier today in the Journal of the A...
(Date:7/22/2008)...ty and Efficacy of Treating Patients with ...SCO, and YONGIN-SI, South Korea, July 22 /PRNewswi...a, Ontario), and its South,Korean partner Green Cr...m,a Phase I clinical trial of its first-in-class l...as well-tolerated and resulted in clear,anti-cance...
(Date:7/22/2008)..., July 22 /- Hyperion,Therapeutics, I...enrollment,in its Phase 1/2 clinical trial to eval...ng effects of HPN-100 (formally called GT4P) versu...with urea cycle disorders,(UCD). The company plans...r,of this year., (Logo: http://www.newscom.com/c...
(Date:7/22/2008)...uly 22 /- NicOx S.A.,(Euron...y completed the,enrollment of 417 osteoarthritis (...linical pharmacology studies in the United States,...e trials are designed to assess the,blood pressure...n and,naproxen, using the Ambulatory Blood Pressur...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3NSF International Acquires David Begg Associates 460 1NSF International Acquires David Begg Associates 460 2Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 1Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 2Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 3Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 4Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 1Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 44 000 e Books now available on ScienceDirect 314 14 000 e Books now available on ScienceDirect 314 2
.../PRNewswire/ -- Results from analyses,looking at...,ulcerative colitis (UC), were presented at Digest...studies were funded by Procter &,Gamble (P&G) Ph...r new information on improvement of quality of lif...mine), which is from a class,of agents known as ...
... 2007 /PRNewswire/ -- A three-year,follow-up sub...clinical trial at EuroPCR 2007 showed that the CYP...lts comparable to coronary,artery bypass graftin...han bare metal stents (BMS) in diabetic patients w..., The CYPHER(R) Stent results in the diabetic po...
Other Medicine Technology:Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 2Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 4